Abstract
Background Relative to males, females are at a higher risk of developing age-related neurocognitive disorders including Alzheimer’s disease. Emerging evidence suggests that reproductive life events such as pregnancy and hormone use may influence female’s cognition later in life. Yet, female’s health has historically been understudied, and little is known about the relationship between female-specific factors and cognition.
Methods Using multiple linear regression, we investigated the associations between reproductive history, exogenous hormone use, apolipoprotein (APOE) ε4 genotype and cognition in 221,124 middle-to older-aged (mean age 56.2 ± 8.0 years) females from the UK Biobank. Performance on six cognitive tasks was assessed, covering four cognitive domains: episodic visual memory, numeric working memory, processing speed, and executive function.
Results A longer reproductive span, older age at menopause, older age at first and last birth, and use of hormonal contraceptives were positively associated with cognitive performance later in life. Number of live births, hysterectomy without oophorectomy and use of hormone therapy showed mixed findings, with task-specific positive and negative associations. Effect sizes were generally small (Cohen’s d < 0.1). While APOE ε4 genotype was associated with reduced processing speed and executive functioning, in a dose-dependent manner, it did not influence the observed associations between female-specific factors and cognition.
Conclusion Our findings support previous evidence of associations between a broad range of female-specific factors and cognition. The positive association between a history of hormonal contraceptive use and cognition later in life showed the largest effect sizes (max. d = 0.1). Future research is needed to investigate the effects of sex hormone exposure and cognition to develop a better understanding of female’s brain health.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
While working on this study, the authors received funding from the Research Council of Norway (Christian K. Tamnes: #223273, #288083, #323951; Lars T. Westlye: #273345, #249795, #298646, #300768, #223273; Ingrid Agartz: #213700, #223273, #250358), the South-Eastern Norway Regional Health Authority (Christian K. Tamnes: #2019069, #2021070, #500189; Lars T. Westlye: #2018076, #2019101, Ingrid Agartz: #2017097, #2019104, #2020020), the European Research Council under the European Union's Horizon 2020 research and innovation programme (Lars T. Westlye: #802998), the Swiss National Science Foundation (Ann-Marie G. de Lange: PZ00P3_193658).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data that support the findings of this study are available through the UK Biobank data access procedures (https://www.ukbiobank.ac.uk/researchers)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are available through the UK Biobank data access procedures.